A family has launched a desperate bid to raise money for life-saving treatment for their five-year-old daughter.
Niamh Curry has the rare and aggressive cancer neuroblastoma and doctors say they have exhausted their treatment options here in the UK.
Niamh’s parents Chris and Samantha are now trying to raise a massive £450,000 to take their daughter to America where treatment for the cancer is more advanced.
There has been an overwhelming response to the appeal with £30,000 raised in the first 11 days and 10,000 people following Niamh’s plight on Twitter.
Celebrities including Jonathan Ross have pledged their support and comedian Jason Manford has donated £1,000.
Mrs Curry, 36, said: “It is amazing how everyone has come together to help us.
“People we don’t know are holding fundraising events for us. It feels like a dream.”
Niamh, who goes to Little Harrowden Primary School with her big sister Hannah, seven, was diagnosed with neuroblastoma just before Christmas 2010.
She has had surgery to remove the tumour on her kidney, several rounds of chemotherapy, radiotherapy and stem cell treatment.
Her parents, of Troon Crescent, Wellingborough, say she has kept smiling throughout her treatment.
But the family were told in November that Niamh was not responding to treatment and had relapsed.
They were offered more chemotherapy to give them more time with their daughter but doctors said there was no chance of a cure.
They are now hoping to reach their fundraising target in order to take Niamh to America, where there are more cases of the disease and more treatment options.
If they can raise the money, Niamh will receive special antibody treatment in Philadelphia.
ABOUT NEUROBLASTOMA AND HOW TO HELP
Neuroblastoma is a childhood cancer. About 100 new cases are diagnosed every year in the UK.
Sometimes there are no symptoms and diagnosis is only made when a tumour is detected, usually in the abdomen.
Neuroblastoma can occur at any age, though most patients are pre-school age children.
Children with advanced neuroblastoma can receive chemotherapy, surgery, radiation therapy, stem cell transplant and immunotherapy, but the long-term survival rate for high-risk neuroblastoma patients remains less than 40 per cent.